Michael B. Chancellor 13D and 13G filings for Lipella Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-17 5:00 pm Unchanged |
2024-10-15 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,642 16.000% |
0 (Unchanged) |
Filing |
| 2024-08-19 4:05 pm Purchase |
2024-08-16 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 209,642 18.800% |
16,667 (+8.64%) |
Filing |
| 2024-03-15 12:15 pm Purchase |
2024-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 192,975 20.000% |
18,113 (+10.36%) |
Filing |
| 2024-03-06 5:03 pm Purchase |
2024-03-04 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 174,862 18.900% |
10,833 (+6.60%) |
Filing |
| 2023-06-21 5:07 pm Purchase |
2023-06-16 | 13D | Lipella Pharmaceuticals Inc. LIPO |
Michael B. Chancellor | 164,029 20.800% |
164,029 (New Position) |
Filing |